Search Results

There are 24570 results for: content related to: Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer

  1. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women

    Intervention Review

    The Cochrane Library

    Shom Goel, Rohini Sharma, Anne Hamilton and Jane Beith

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD004562.pub4

  2. You have free access to this content
    Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: A randomized trial


    Volume 45, Issue 4, 15 February 1980, Pages: 735–741, John H. Glick, Richard H. Creech, Susan Torri, Christopher Holroyde, Harvey Brodovsky, Robert B. Catalano and Michael Varano

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19800215)45:4<735::AID-CNCR2820450421>3.0.CO;2-S

  3. You have free access to this content
    Tamoxifen and ATP synergistically activate Cl release by cultured bovine pigmented ciliary epithelial cells

    The Journal of Physiology

    Volume 525, Issue 1, May 2000, Pages: 183–193, Claire H. Mitchell, Kim Peterson-Yantorno, Miguel Coca-Prados and Mortimer M. Civan

    Version of Record online : 13 AUG 2004, DOI: 10.1111/j.1469-7793.2000.00183.x

  4. You have free access to this content
    Chemoprevention: Drug pricing and mortality


    Volume 107, Issue 5, 1 September 2006, Pages: 950–958, Joy Melnikow, Christina Kuenneth, L. Jay Helms, Amber Barnato, Miriam Kuppermann, Stephen Birch and James Nuovo

    Version of Record online : 24 JUL 2006, DOI: 10.1002/cncr.22075

  5. Tamoxifen and the female genital tract

    International Journal of Gynecological Cancer

    Volume 8, Issue 1, January/February 1998, Pages: 6–15, Ugwumadu, Carmichael and Neven

    Version of Record online : 5 JAN 2002, DOI: 10.1046/j.1525-1438.1998.09726.x

  6. You have free access to this content
    Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes

    British Journal of Pharmacology

    Volume 171, Issue 24, December 2014, Pages: 5624–5635, Philipp Y Maximov, Russell E McDaniel, Daphne J Fernandes, Valeriy R Korostyshevskiy, Puspanjali Bhatta, Thomas E Mürdter, David A Flockhart and V Craig Jordan

    Version of Record online : 1 DEC 2014, DOI: 10.1111/bph.12864

  7. You have free access to this content
    Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer

    British Journal of Clinical Pharmacology

    Volume 77, Issue 4, April 2014, Pages: 695–703, Hiltrud Brauch and Matthias Schwab

    Version of Record online : 20 MAR 2014, DOI: 10.1111/bcp.12229

  8. Effects of tamoxifen on the cytology of the uterine cervix in breast cancer patients

    Diagnostic Cytopathology

    Volume 19, Issue 6, December 1998, Pages: 417–422, Bonnie L. Gill, Jean F. Simpson, George Somlo, Kathryn F. McGonigle and Sharon P. Wilczynski

    Version of Record online : 11 DEC 1998, DOI: 10.1002/(SICI)1097-0339(199812)19:6<417::AID-DC3>3.0.CO;2-P

  9. Postoperative tamoxifen for ductal carcinoma in situ

    Intervention Review

    The Cochrane Library

    Helen Staley, Iain McCallum and Julie Bruce

    Published Online : 17 OCT 2012, DOI: 10.1002/14651858.CD007847.pub2

  10. Endocrine Therapy in Breast Cancer Management

    Clinical Endocrine Oncology, Second Edition

    Ian D. Hay, John A.H. Wass, Pages: 609–617, 2009

    Published Online : 27 JAN 2009, DOI: 10.1002/9781444300222.ch83

  11. Tamoxifen in men: a review of adverse events


    Volume 4, Issue 5, September 2016, Pages: 776–788, E. Wibowo, P. A. Pollock, N. Hollis and R. J. Wassersug

    Version of Record online : 6 MAY 2016, DOI: 10.1111/andr.12197

  12. You have free access to this content
    New Molecular Classifications of Breast Cancer

    CA: A Cancer Journal for Clinicians

    Volume 59, Issue 5, September/October 2009, Pages: 303–313, Mary Cianfrocca and William Gradishar

    Version of Record online : 4 SEP 2009, DOI: 10.3322/caac.20029

  13. You have free access to this content
    Proven value of translational research with appropriate animal models to advance breast cancer treatment and save lives: the tamoxifen tale

    British Journal of Clinical Pharmacology

    Volume 79, Issue 2, February 2015, Pages: 254–267, V. Craig Jordan

    Version of Record online : 20 JAN 2015, DOI: 10.1111/bcp.12440

  14. Granulosa cell tumor of the ovary after long-term use of tamoxifen and toremifene

    Journal of Obstetrics and Gynaecology Research

    Volume 38, Issue 12, December 2012, Pages: 1379–1384, Tomohito Tanaka, Takashi Kato and Masahide Ohmichi

    Version of Record online : 21 MAY 2012, DOI: 10.1111/j.1447-0756.2012.01878.x

  15. Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data

    Journal of Surgical Oncology

    Volume 93, Issue 7, 1 June 2006, Pages: 585–592, G. Grana

    Version of Record online : 16 MAY 2006, DOI: 10.1002/jso.20564

  16. You have free access to this content
    The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer


    Volume 106, Issue 12, 15 June 2006, Pages: 2576–2582, Rinaa S. Punglia, Karen M. Kuntz, Eric P. Winer, Jane C. Weeks and Harold J. Burstein

    Version of Record online : 15 MAY 2006, DOI: 10.1002/cncr.21919

  17. Tamoxifen inhibits migration of estrogen receptor-negative hepatocellular carcinoma cells by blocking the swelling-activated chloride current

    Journal of Cellular Physiology

    Volume 228, Issue 5, May 2013, Pages: 991–1001, Jianwen Mao, Jian Yuan, Liwei Wang, Haifeng Zhang, Xiaobao Jin, Jiayong Zhu, Hongzhi Li, Bin Xu and Lixin Chen

    Version of Record online : 28 JAN 2013, DOI: 10.1002/jcp.24245

  18. Tamoxifen's effects on the zebra finch song system are estrogenic, not antiestrogenic

    Journal of Neurobiology

    Volume 22, Issue 9, December 1991, Pages: 957–969, Greta A. Mathews and Arthur P. Arnold

    Version of Record online : 11 OCT 2004, DOI: 10.1002/neu.480220907

  19. Endocrine Treatment and Prevention of Breast and Gynecological Cancers Vth International Symposium of the Flemish Gynecological Oncology Group, January 26–28, 2006

    International Journal of Gynecological Cancer

    Volume 16, Issue s2, September 2006, Pages: 479–491, P. NEVEN, I. VERGOTE, F. AMANT, P. BERTELOOT, E. De JONGE, C. DE ROP, P. DE SUTTER, A. MAKAR and J. VAN GINDERACHTER

    Version of Record online : 26 SEP 2006, DOI: 10.1111/j.1525-1438.2006.00673.x

  20. Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy

    British Journal of Urology

    Volume 77, Issue 1, January 1996, Pages: 76–85, Y-S. Pu, T-S. Hsieh, A-L. Cheng, N-F. Tseng, I-J. Su, C-Y. Hsieh, M-K. Lai and T-C. Tsai

    Version of Record online : 29 OCT 2003, DOI: 10.1046/j.1464-410X.1996.82712.x